HemosIL Products for ACL Analyzers

HemosIL Silica Clotting Time

Clotting / IVD

Catalog #: 20004800

Intended Use: For the detection of Lupus Anticoagulants (LA) in human citrated plasma on IL coagulation systems.

Principle: Silica Clotting Time (SCT) contains both SCT Screen and SCT Confirm reagents. SCT Screen is poor in phospholipid, making it sensitive to LA. The additional amount of phospholipid in SCT Confirm neutralizes LA to produce shorter clotting times.

Vials and Volumes

  • 3 x 5 mL SCT Screen (liq)
  • 3 x 5 mL SCT Confirm (liq)
  • 3 x 10 mL SCT CaCl2 (liq)

Main Features

  • Screen (low phospholipid concentration) and Confirm (high phospholipid concentration) in the same kit
  • Liquid formulation, easy to use, fully automated
  • Suitable for mixing studies
  • Suitable for oral anticoagulant-treated patient samples

Downloads

Name Type Size
HemosIL Hemostasis Reagents - A comprehensive test menu of assays to support disease management (Because lIfe is now brochure) application/pdf 648.13 kB
HemosIL Silica Clotting Time (SCT) ISTH 05 Presentation application/pdf 129.84 kB
HemosIL Silica Clotting Time (SCT) J Clin Lab 05 Article application/pdf 123.87 kB
HemosIL Silica Clotting Time (SCT) Material Safety Data Sheet (MSDS) application/pdf 54.57 kB
Instrumentation Laboratory Hemostasis Catalog application/pdf 908.14 kB